ScienceBreaking NewsBreakingLatest News
Scientists Discover How Pancreatic Cancer Rewrites Its DNA to Escape Treatment
Sentiment: NeutralHigh Priority
What Happened?
Researchers at NYU Langone Health have found that pancreatic cancer alters its DNA, enabling it to resist treatment and spread. The study examined nearly half a million cancer cells to uncover these mechanisms.
Key points
- The study focused on pancreatic ductal adenocarcinoma, a highly aggressive cancer.
- 85% of patients diagnosed with this cancer die within five years.
- Researchers identified genetic changes in nearly half a million cancer cells.
- MYC gene activity was linked to aggressive cancer cell populations.
- Blocking MYC activity made aggressive cells revert to a less aggressive state.
- Certain clones of cancer cells showed increased TIGIT gene activity, aiding immune evasion.
Key insights
- Targeting MYC may enhance treatment effectiveness against pancreatic cancer.
- The study highlights the importance of single-cell analysis in understanding cancer evolution.
- Identifying genetic markers could lead to personalized therapies for patients.
Why it matters
Understanding these genetic changes could lead to new treatment strategies for pancreatic cancer.
Tags
Entities
NYU Langone Health· OrganizationMYC· GeneTIGIT· GeneNature Genetics· EventDespoina Kalfakakou· PersonAristotelis Tsirigos· Person
Source
Science Daily
